Gain Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Gain Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Gain Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Gain Therapeutics by Bridgeway Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $51k | 40k | 1.28 |
| 2024-03-31 | $113k | 30k | 3.77 |
| 2023-09-30 | $149k | 46k | 3.23 |
| 2023-06-30 | $207k | 46k | 4.48 |
| 2023-03-31 | $289k | 60k | 4.82 |
| 2022-12-31 | $188k | 60k | 3.13 |
| 2022-09-30 | $130k | 40k | 3.25 |
| 2022-06-30 | $144k | 40k | 3.60 |
| 2022-03-31 | $163k | 40k | 4.08 |
| 2021-12-31 | $267k | 50k | 5.34 |
| 2021-09-30 | $372k | 50k | 7.44 |
| 2021-06-30 | $501k | 50k | 10.02 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management